Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only

Clinical trial NCT00950911 · COMPLETED

Trial details

NCT number: NCT00950911
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bone Metastases in Men With Hormone-Refractory Prostate Cancer Bone Metastases in Subjects With Advanced Breast Cancer Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma

Start date: 2009-07-01
Primary completion: 2012-02-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.